Chancellor Rachel Reeves Aims for Focused Measures on Bills in Forthcoming Budget
Treasury head Reeves has revealed she is planning "targeted steps to address household expense pressures" in the forthcoming Budget.
In comments to the BBC, she noted that reducing price rises is a shared duty of both the government and the Bank of England.
The UK's inflation rate is expected to be the most elevated among the G7 industrialized countries this year and the following year.
Possible Utility Bill Interventions
Reports indicate the government could take action to bring down utility costs, for example by cutting the present 5% level of value-added tax charged on energy.
An additional possibility is to lower some of the government charges currently included in household expenses.
Fiscal Constraints and Expert Predictions
The administration will receive the next draft from the independent fiscal watchdog, the Office for Budget Responsibility, on the start of the week, which will clarify how much space there is for these actions.
The consensus from most analysts is that the Chancellor will have to declare tax rises or expenditure reductions in order to adhere to her voluntary fiscal targets.
Previously on the same day, analysis suggested there was a twenty-two billion pound gap for the chancellor to address, which is at the lower end of forecasts.
"There's a collective responsibility between the Bank of England and the administration to further reduce some of the causes of inflation," the Chancellor told reporters in Washington, at the annual meetings of the IMF and World Bank.
Revenue Pledges and Global Concerns
While much of the focus has been on probable tax rises, the chancellor said the latest information from the OBR had not changed her vow to election pledges not to raise rates on earnings tax, sales tax or National Insurance.
She attributed an "uncertain world" with growing geopolitical and trade issues for the fiscal tax moves, likely to be targeted on those "most able to pay."
International Trade Tensions
Commenting on worries about the UK's commercial links with China she said: "The UK's national security always come first."
Last week's declaration by Chinese authorities to increase trade restrictions on critical minerals and other resources that are crucial for advanced tech manufacturing led American leader the US President to propose an additional 100% tariff on imports from China, increasing the risk of an full-scale trade war between the two global powers.
The US Treasury Secretary called the Chinese decision "economic coercion" and "a international production control attempt."
Questioned on considering the American proposal to join its battle with the Asian nation, the Chancellor said she was "very concerned" by China's actions and encouraged the Beijing authorities "to avoid restrictions and limit trade."
She said the move was "harmful for the global economy and causes additional challenges."
"In my view there are sectors where we must confront China, but there are also valuable opportunities to sell into Chinese markets, including financial services and other sectors of the economy. We've got to achieve that equilibrium appropriate."
The Treasury chief also stated she was collaborating with other major economies "on our own essential resources plan, so that we are less reliant."
Health Service Medicine Costs and Funding
Reeves also recognized that the price the National Health Service pays for drugs could rise as a consequence of current discussions with the Trump administration and its pharmaceutical firms, in return for reduced taxes and capital.
Some of the biggest global pharmaceutical manufacturers have said in recent statements that they are either delaying or canceling projects in the United Kingdom, with several blaming the insufficient payments they are obtaining.
Recently, the Science Minister said the price the NHS spends on medicines would have to go up to stop companies and drug research funding departing from the UK.
The Chancellor told the BBC: "We have seen as a result of the pricing regime, that drug testing, innovative medicines have not been available in the UK in the way that they are in other European countries."
"Our aim is to make sure that people getting treatment from the NHS are able to obtain the best life-saving treatments in the world. And so we are looking at all of that, and... looking to attract increased funding into Britain."